Company: EUDAW
Filing Date: 2025-08-08
Form Type: 424B5
Source: 0001493152-25-011729
Chunk: 11

Company: EUDA Health Holdings Ltd
Filing Date: 2025-08-08
Form: 424B5
Chunk 11
---
 in his sole direction to file a registration statement with the SEC for the resale of any or all of these 8,571,428 ordinary shares. The resale of these shares could cause a significant decline on the trading price of the Company’s ordinary shares.

| S-6 |

Certain shareholders will continue to own a significant percentage of our ordinary shares and, if they choose to act together, will be able to exert significant control over matters subject to stockholder approval.

We have two significant shareholders, one holding approximately 25% and the other holding approximately 28% of the currently issued and outstanding shares immediately prior to this offering. Therefore, acting together, they have the ability to substantially influence all matters submitted to our shareholders for approval. For example, these holders may be able to control the appointment of our management, elections and removal of directors, amendments of our organizational documents, or approval of any merger, sale of assets, or other major corporate transaction. The interests of these holders may not always coincide with our corporate interests or the interests of other shareholders, and they may act in a manner with which our shareholders may not agree or that may not be in the best interests of our other shareholders. This concentration of ownership may have the effect of delaying, deferring, or preventing a change in control, impeding a merger, consolidation, takeover or other business combination involving us, or discouraging a potential acquiror from making a tender offer or otherwise attempting to obtain control of our business, even if such a transaction would benefit other shareholders. So long as they continue to own a significant amount of our equity, these holders will be able to strongly influence or effectively control our decisions.

The Company has a part-time Interim Chief Financial Officer and the management team has limited experience working together.

Effective September 3, 2024, Ms. Vivian Tay has served as the Company’s part-time Interim Chief Financial Officer while the Company searches for a full-time successor CFO. Ms. Tay is currently the Accounts Director at 8i Enterprises Pte. Ltd., of which Mr. Meng Dong (James) Tan is the sole shareholder and director. Mr. Tan is a significant shareholder of the Company, holding approximately 25% of the currently issued and outstanding ordinary shares of the Company. The Company’s management team is currently comprised of Mr. Alfred Lim, the Chief Executive Officer and Executive Director, and Ms. Vivian Tay, the Interim Chief Financial Officer. The Company’s management team has limited experience working together, managing a publicly traded company, interacting